BioSpace News Archive

Company will need to provide a new assay to satisfy FDA before commencing Phase I trials.

The new year began with a fairly low level of clinical trial news. Here’s a look.

When Chinook Therapeutics looks at 2021, it foresees a host of clinical trials that will bring precision medicine to the kidney disease space.

Blacksmith Medicines announced on Friday it had secured a multimillion dollar seed funding deal from Eli Lilly and has entered into a research collaboration with the Indianapolis-based pharmaceutical giant to advance human metalloenzyme targets.

Please note that the embedded hyperlinks in the press release below have been corrected from a release issued under the same headline earlier today. Cullinan Management, Inc. , a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients, announced today the pricing of its upsized initial public offering of 11,900,000 shares of c

Demand for dental restoratives is on askyward rise as a huge proportion of the worldwide population is focusing on oral health, the incidences of dental decay are rapidlyfalling.

With the presence of a number of large-, medium-, and small-scale vendors, the global bioactive wound management market demonstrates a competitive and fragmented business landscape, finds a new research study by Transparency Market Research.

The global blood cell analyzer market depicts a highly competitive and expansive vendor landscape to exist, says Transparency Market Research on the basis of a recently published report.

In order to up their sales and revenues, savvy companies in the global guidewires market are expending time and money on research and development of better products having sophisticated features to cater to various medical procedures.

The global in-vitro diagnostics quality control market is prognosticated to grow notably in forthcoming years.